Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Conditioning Regimens

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients

Abstract

The aim of this study was to investigate the importance of busulfan concentrations for short- and long-term survival in autologous (ABMT) and allogeneic (BMT) bone marrow transplant recipients. One hundred and seventy-three patients were included in the study; 87 ABMT and 85 BMT patients. All patients received busulfan 1 mg/kg four times daily for 4 days followed by cyclophosphamide 60 mg/kg/day for 2 days. Busulfan concentrations were measured and the mean concentration calculated for each patient. There was no difference in busulfan concentrations between BMT and ABMT patients. Patients who died before day 100 had significantly higher busulfan concentrations than patients surviving beyond day 100 (719 ng/ml vs 589 ng/ml; P < 0.02). bmt patients who had busulfan concentrations in the highest quartile had significantly worse disease-free survival (dfs) and survival compared to other patients. the transplant-related mortalities (trm) at 100 days were 29 and 14% in patients in the highest quartile and remaining patients, respectively. there was no difference in relapse incidence. high busulfan concentrations were associated with increased trm but no difference in either survival or dfs could be found for the abmt patients. monitoring of busulfan concentrations is important in reducing the risk for trm in patients undergoing bone marrow transplantation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungman, P., Hassan, M., Békássy, A. et al. High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients. Bone Marrow Transplant 20, 909–913 (1997). https://doi.org/10.1038/sj.bmt.1700994

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700994

Keywords

This article is cited by

Search

Quick links